Search
for
Sort by
Research 61–90 of 270
- Testosterone therapy for transgender men
- An Update of Congenital Adrenal Hyperplasia
- Dermatologic manifestations of endocrine disorders
- Diagnosis of hyperandrogenism: clinical criteria
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Dermatology of androgen-related disorders
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- ACNE
- Nonclassic adrenal hyperplasia
- Safety of testosterone use in women
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Endocrine-skin interactions
- Evidence-based approach to cutaneous hyperandrogenism in women
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Endocrine evaluation of hirsutism
- The rationale for physiological testosterone replacement in women
- Prescribing testosterone and DHEA: The role of androgens in women
- Hormone therapy in acne
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Assessment, diagnosis and treatment of a patient with hirsutism
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution
- Chemical pharmacotherapy options for managing adult acne
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Gonadal Dysgenesis: Associations between Clinical Features and Sex of Rearing.
- Physiology and Medical Treatments for Alopecia
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)